Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Living Cell Technologies ( (AU:1AI) ) has issued an update.
Algorae Pharmaceuticals Limited has issued 1,000,000 fully paid ordinary shares as of November 7, 2025, without disclosure to investors under specific provisions of the Corporations Act 2001. This issuance aligns with regulatory compliance, and the company confirms there is no undisclosed information required under the Act, potentially impacting its market operations and investor relations.
More about Living Cell Technologies
Algorae Pharmaceuticals Limited operates within the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Australian Securities Exchange under the ticker ASX: 1AI.
Average Trading Volume: 2,838,828
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$15.19M
Learn more about 1AI stock on TipRanks’ Stock Analysis page.